Swiss operators described the first-in-human placement of the novel Tricento transcatheter heart valve, in a woman with severe tricuspid regurgitation. Three months after the procedure, caval vein regurgitant volume was reduced and the patient showed symptomatic and clinical improvement, they reported in EuroIntervention.